Stockscreener 앱 받기
2.88
3.03%
-0.09
시간 외 거래:
2.84
-0.04
-1.39%
Purple Biotech Ltd Adr 주식(PPBT)의 최신 뉴스
Purple Biotech Identifies Potential New Serum Biomarker for its Lead Oncology Therapeutic Candidate CM24: Associated with 79% Reduction in Risk of Death - GlobeNewswire Inc.
U.S. shares higher at close of trade; Dow Jones Industrial Average up 0.65% - MSN
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.65% - MSN
PPBT stock touches 52-week low at $3.52 amid market challenges - Investing.com India
PPBT stock touches 52-week low at $5.89 amid market challenges - Investing.com India
Purple Biotech price target raised by H.C. Wainwright, maintains Buy rating - Investing.com India
Ratio Review: Analyzing Purple Biotech Ltd ADR (PPBT)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex
What Makes Purple Biotech (PPBT) a New Buy Stock - Yahoo Finance
Purple Biotech stock target cut on trial cohort issue - Investing.com
Purple Biotech granted Nasdaq compliance extension - Investing.com
95 Promising Stocks You Can Currently Buy for Less Than $5 Per Share - GOBankingRates
Purple Biotech stock retains Buy rating from H.C. Wainwright - Investing.com
Purple Biotech Ltd ADR (PPBT) Stock Behavior Isn't As Predictable As You Think – Stocks Register - Stocks Register
Financial Fitness Check: Examining Purple Biotech Ltd ADR (PPBT)’s Key Ratios - The Dwinnex
You might want to take a look at Purple Biotech Ltd ADR (PPBT) now – Sete News - SETE News
Why Purple Biotech (PPBT) Shares Are Trading Lower - Quantisnow
The Significance of Moving Averages in Purple Biotech Ltd ADR Inc. (PPBT) Price Performance - The InvestChronicle
A closer look at Purple Biotech Ltd ADR (PPBT)'s stock price trends – US Post News - US Post News
Manulife Financial Corp. [MFC] gain 19.91% so far this year. What now? – The DBT News - The DBT News
Purple Biotech Ltd ADR Inc. (PPBT) Price Performance: The Role of Volume and Liquidity - The InvestChronicle
Analyzing PPBT's price-to-book ratio for the last quarter – US Post News - US Post News
Purple Biotech Ltd ADR (PPBT) Stock: A Year of Market Movement, Down and Up - The InvestChronicle
Insider's View: Deciphering Purple Biotech Ltd ADR (PPBT)'s Financial Health Through Ratios – DWinneX - The Dwinnex
Purple Biotech shares target cut by Jones Trading on interim Ph2 data - Investing.com India
Purple Biotech shares target cut by Jones Trading on interim Ph2 data By Investing.com - Investing.com
A stock that deserves closer examination: Purple Biotech Ltd ADR (PPBT) – US Post News - US Post News
Purple Biotech Ltd ADR (PPBT) Stock: Uncovering 52-Week Market Trends - The InvestChronicle
Here's Why Purple Biotech Ltd. Sponsored ADR (PPBT) Could be Great Choice for a Bottom Fisher - Yahoo Finance
7 High-Potential Penny Stocks in the Biotech Sector - InvestorPlace
Best Penny Stocks Under $1 To Buy Now - AOL
A new, genetically modified purple tomato may hit the grocery market stands - CNN
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday - The Globe and Mail
The Daily Biotech Pulse: DermTech Soars On Contract, Fluidigm Plunges On Earnings, Decision Day For Regeneron, Bioventus Debuts - Benzinga
The Daily Biotech Pulse: Dynavax Poaches GSK Vaccine Exec, KalVista Jumps On Data Readout, Corcept Issues - Benzinga
The Daily Biotech Pulse: FDA Greenlights Merck's Heart Failure Drug, Histogen Hit With Clinical Hold, Aptorum Gets Nod For Commencing Human Study - Markets Insider
Purple Biotech (PPBT) Stock Price, News & Analysis - MarketBeat
2.02%
0.47%
자본화:
|
볼륨(24시간):